Figure 1

1.GINA: World Technique for Bronchial asthma Administration and Prevention. Out there in, 26/01/2017 (2016).2.Hogan, S. P. et al. Eosinophils: organic properties and position in well being and illness. Clin. Exp. Allergy.
38, 709–750 (2008).three.Barnes, P. J. et al. Exhaled nitric oxide in pulmonary illnesses: a complete evaluation. Chest.
138, 682–692 (2010).four.Feder, L. S. et al. Position of nitric oxide on eosinophilic lung irritation in allergic mice. Am. J. Respir. Cell. Mol. Biol.
17, 436–442 (1997).5.Xiong, Y., Karupiah, G., Hogan, S. P., Foster, P. S. & Ramsay, A. J. Inhibition of allergic airway irritation in mice missing nitric oxide synthase 2. J. Immunol.
162, 445–452 (1999).6.Shore, S. A. & Johnston, R. A. Weight problems and bronchial asthma. Pharmacol. Ther.
110, 83–102 (2006).7.Calixto, M. C. et al. Weight problems enhances eosinophilic irritation in a murine mannequin of allergic bronchial asthma. Br. J. Pharmacol.
159, 617–625 (2010).eight.Leiria, L. O. et al. Elevated airway reactivity and hyperinsulinemia in overweight mice are linked by ERK signaling in mind stem cholinergic neurons. Cell Rep.
11, 934–943 (2015).9.Calixto, M. C. et al. Metformin attenuates the exacerbation of the allergic eosinophilic irritation in excessive fat-diet-induced weight problems in mice. PLoS One
eight(10), e76786 (2013).10.Shimabukuro, M., Ohneda, M., Lee, Y. & Unger, R. H. Position of nitric oxide in obesity-induced beta cell illness. J. Clin. Make investments.
100, 290–295 (1997).11.Jankovic, A. et al. Concentrating on the nitric oxide/superoxide ratio in adipose tissue: relevance in weight problems and diabetes administration. Br. J. Pharmacol. (2016).12.Perreault, M. & Marette, A. Focused disruption of inducible nitric oxide synthase protects towards obesity-linked insulin resistance in muscle. Nat. Med.
7, 1138–1143 (2001).13.Cordes, C. M., Bennett, R. G., Siford, G. L. & Hamel, F. G. Nitric oxide inhibits insulin-degrading enzyme exercise and performance by way of S-nitrosylation. Biochem Pharmacol.
77, 1064–1073 (2009).14.Carvalho-Filho, M. A., Ueno, M., Carvalheira, J. B., Velloso, L. A. & Saad, M. J. Focused disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab.
291, E476–482 (2006).15.Pilon, G. et al. Endotoxin mediated-iNOS induction causes insulin resistance through ONOO− induced tyrosine nitration of IRS-1 in skeletal muscle. Plos One.
5, e15912 (2010).16.Lloyd, C. M. & Saglani, S. Eosinophils within the highlight: Discovering the hyperlink between weight problems and bronchial asthma. Nat. Med.
19, 976–977 (2013).17.Baur, J. A. et al. Resveratrol improves well being and survival of mice on a high-calorie weight-reduction plan. Nature.
444, 337–342 (2006).18.Lagouge, M. et al. Resveratrol improves mitochondrial perform and protects towards metabolic illness by activating SIRT1 and PGC-1alpha. Cell.
127, 1109–1122 (2006).19.Solar, C. et al. SIRT1 improves insulin sensitivity beneath insulin-resistant circumstances by repressing PTP1B. Cell. Metab.
6, 307–319 (2007).20.Um, J. H. et al. AMP-activated protein kinase-deficient mice are proof against the metabolic results of resveratrol. Diabetes.
59, 554–563 (2010).21.Barger, J. L. et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards getting old parameters in mice. PLoS One.
three(6), e2264 (2008).22.Su, H. C., Hung, L. M. & Chen, J. Ok. Resveratrol, a pink wine antioxidant, possesses an insulin-like impact in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab.
290, E1339–1346 (2006).23.Szkudelski, T. & Szkudelska, Ok. Anti-diabetic results of resveratrol. Ann. N. Y. Acad. Sci.
1215, 34–39 (2011).24.André, D. M. et al. Remedy with resveratrol attenuates obesity-associated allergic airway irritation in mice. Int. Immunopharmacol.
38, 298–305 (2016).25.Cersosimo, E., Xu, X. & Musi, N. Potential position of insulin signaling on vascular easy muscle cell migration, proliferation, and irritation pathways. Am. J. Physiol. Cell. Physiol.
302(four), C652–657 (2012).26.Saltiel, A. R. & Kahn, C. R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature.
414, 799–806 (2001).27.Nie, Y., Ma, R. C., Chan, J. C., Xu, H. & Xu, G. Glucose-dependent insulinotropic peptide impairs insulin signaling through inducing adipocyte irritation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes. FASEB J.
26, 2383–2393 (2012).28.Al-Shawwa, B. A., Al-Huniti, N. H., DeMattia, L. & Gershan, W. Bronchial asthma and insulin resistance in morbidly overweight kids and adolescents. J. Bronchial asthma.
44, 469–473 (2007).29.Thuesen, B. H., Husemoen, L. L., Hersoug, L. G., Pisinger, C. & Linneberg, A. Insulin resistance as a predictor of incident asthma-like signs in adults. Clin. Exp. Allergy.
39, 700–707 (2009).30.Arshi, M., Cardinal, J., Hill, R. J., Davies, P. S. & Wainwright, C. Bronchial asthma and insulin resistance in kids. Respirology.
15, 779–784 (2010).31.Ma, J., Xiao, L. & Knowles, S. B. Weight problems, insulin resistance and the prevalence of atopy and bronchial asthma in US adults. Allergy.
65, 1455–1463 (2010).32.Julia, V., Macia, L. & Dombrowicz, D. The impression of weight-reduction plan on bronchial asthma and allergic illnesses. Nat. Rev. Immunol.
15(5), 308–322 (2015).33.DeFronzo, R. A. & Tripathy, D. Skeletal muscle insulin resistance is the first defect in kind 2 diabetes. Diabetes Care.
32, S157–163 (2009).34.Leto, D. & Saltiel, A. R. Regulation of glucose transport by insulin: site visitors management of GLUT4. Nat. Rev. Mol. Cell. Biol.
13, 383–396 (2012).35.Karlsson, H. Ok. et al. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of kind 2 diabetic topics. Diabetes.
54, 1692–1697 (2005).36.Hay., N. Akt isoforms and glucose homeostasis- the leptin connection. Traits Endocrinol. Metab.
22, 66–73 (2011).37.da Costa, R. M. et al. TNF-α induces vascular insulin resistance through optimistic modulation of PTEN and decreased Akt/eNOS/NO signaling in excessive fats diet-fed mice. Cardiovasc Diabetol.
15, 119 (2016).38.Molina, S. A. et al. Insulin signaling through the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier perform in a CFTR-dependent method. Am. J. Physiol. Lung Cell Mol. Physiol.
321, L688–L702 (2017).39.Greene, M. W., Morrice, N., Garofalo, R. S. & Roth, R. A Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta. Biochem. J.
15, 105–116 (2004).40.Gual, P., Le Marchand-Brustel, Y. & Tanti, J. F. Constructive and unfavourable regulation of insulin signaling by way of IRS-1 phosphorylation. Biochimie.
87, 99–109 (2005).41.Aguirre, V., Uchida, T., Yenush, L., Davis, R. & White, M. F. The c-Jun NH(2)- terminal kinase promotes insulin resistance throughout affiliation with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem.
275, 9047–9054 (2000).42.Hirosumi, J. et al. A central position for JNK in weight problems and insulin resistance. Nature.
420, 333–336 (2002).43.Liang, H. et al. Blockade of tumor necrosis issue (TNF) receptor kind 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced weight problems and insulin resistance. Endocrinology.
149, 2943–2951 (2008).44.Maillet, I. et al. Allergic lung irritation is mediated by soluble tumor necrosis issue (TNF) and attenuated by dominant-negative TNF biologics. Am J Respir Cell Mol Biol.
45, 731–739 (2011).45.Ganster, R. W., Taylor, B. S., Shao, L. & Geller, D. A. Advanced regulation of human inducible nitric oxide synthase gene transcription byStat 1 and NF-kappa B. Proc. Natl. Acad. Sci. USA
98, 8638–8643 (2001).46.Tsuchiya, Ok. et al. Continual blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in excessive fat-induced overweight mice. Endocrinology.
148, 4548–4556 (2007).47.Szabó, C. et al. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and shield towards peroxynitrite-induced oxidative injury. J. Biol. Chem.
272, 9030–9036 (1997).48.Ott, C. et al. Position of superior glycation finish merchandise in mobile signaling. Redox. Biol.
2, 411–429 (2014).49.Nagai, R., Murray, D. B., Metz, T. O. & Baynes, J. W. Chelation: a basic mechanism of motion of AGE inhibitors, AGE breakers, and different inhibitors of diabetes issues. Diabetes.
61(three), 549–559 (2012).50.Liu, Ok., Zhou, R., Wang, B. & Mi, M. T. Impact of resveratrol on glucose management and insulin sensitivity: a meta-analysis of 11 randomized managed trials. Am. J. Clin. Nutr.
99, 1510–1519 (2014).51.Hong, H. J. et al. Results of resveratrol on the insulin signaling pathway of overweight mice. J. Vet. Sci.
15, 179–85 (2014).52.Sideleva, O., Black, Ok. & Dixon, A. E. Results of weight problems and weight reduction on airway physiology and irritation in bronchial asthma. Pulm. Pharmacol. Ther.
26, 455–458 (2013).53.Chang, C. C., Lin, Ok. Y., Peng, Ok. Y., Day, Y. J. & Hung, L. M. Resveratrol exerts anti-obesity results in high-fat weight-reduction plan overweight mice and shows differential dosage results on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells. Endocr. J.
63, 169–178 (2016).54.Rieder, S. A., Nagarkatti, P. & Nagarkatti, M. A number of anti-inflammatory pathways triggered by resveratrol result in amelioration of staphylococcal enterotoxin B-induced lung damage. Br. J. Pharmacol.
167, 1244–1258 (2012).55.Burks, D. J. et al. IRS-2 pathways combine feminine replica and vitality homeostasis. Nature
407, 377–382 (2000).


Please enter your comment!
Please enter your name here